Trevi Therapeutics (TRVI) Stock Chart & Stock Price History $6.10 -0.10 (-1.61%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Trevi Therapeutics Stock Price Performance 5 Day Performance+7.01%1 Month Performance-11.85%3 Month Performance+57.41%6 Month Performance+85.94%Year-To-Date Performance+44.42%1 Year Performance+123.26% Receive TRVI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Trevi Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address TRVI Stock Chart for Wednesday, April, 16, 2025 TRVI Chart by TradingViewRemove Ads Trevi Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/15/2025$5.95$6.20+4.20%$6.22$5.88847,571 shs$599.43 million04/14/2025$5.56$5.95+7.01%$6.00$5.521.19 million shs$575.26 million04/11/2025$5.28$5.56+5.30%$5.56$5.123.70 million shs$537.55 million04/10/2025$5.40$5.28-2.22%$5.32$4.851.22 million shs$510.48 million04/09/2025$5.30$5.40+1.89%$5.58$5.062.89 million shs$522.08 million04/09/2025$5.30$5.40+1.89%$5.58$5.062.89 million shs$522.08 million04/08/2025$5.78$5.30-8.30%$6.06$5.211.62 million shs$512.42 million04/08/2025$5.78$5.30-8.30%$6.06$5.211.62 million shs$512.42 million04/07/2025$6.05$5.78-4.46%$6.15$5.431.80 million shs$558.82 million04/04/2025$6.22$6.05-2.73%$6.11$5.781.47 million shs$584.93 million Get the Latest News and Ratings for TRVI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Trevi Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/03/2025$6.28$6.22-0.96%$6.25$5.851.06 million shs$601.36 million04/02/2025$6.01$6.28+4.49%$6.40$5.781.26 million shs$607.16 million04/01/2025$6.29$6.01-4.45%$6.23$5.652.74 million shs$581.06 million03/31/2025$6.50$6.29-3.23%$6.50$6.102.56 million shs$608.13 million03/28/2025$6.53$6.50-0.46%$6.68$6.36944,488 shs$628.43 million03/27/2025$6.47$6.53+0.93%$6.56$6.371.18 million shs$631.33 million03/26/2025$6.61$6.47-2.12%$6.69$6.391.06 million shs$625.53 million03/25/2025$6.40$6.61+3.28%$6.79$6.371.05 million shs$639.07 million03/24/2025$6.47$6.40-1.08%$6.52$6.221.17 million shs$491.94 million03/21/2025$6.61$6.47-2.12%$6.62$6.373.74 million shs$497.32 million03/20/2025$6.81$6.61-2.94%$6.79$6.601.06 million shs$508.08 million03/19/2025$6.56$6.81+3.81%$6.98$6.601.73 million shs$523.46 million03/18/2025$6.54$6.56+0.31%$7.14$6.402.49 million shs$504.24 million03/17/2025$6.75$6.54-3.11%$6.73$6.381.95 million shs$502.70 million Related Companies MLTX Stock Price Chart AMRX Stock Price Chart RXRX Stock Price Chart VCEL Stock Price Chart MIRM Stock Price Chart SDGR Stock Price Chart DNLI Stock Price Chart MTSR Stock Price Chart BHVN Stock Price Chart TARS Stock Price Chart Receive TRVI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Trevi Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TRVI) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredFirst look: The $3,500 iPhoneDid you hear that just before Trump's tariffs took effect, Apple sent five cargo planes packed with MacBooks a...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trevi Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Trevi Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TRVI Stock Free TRVI Stock Alerts